Exelixis reported $274.84M in Operating Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 173.33M 14.84M
Acceleron Pharma XLRN:US $ 88.36M 4.9M
Agios Pharmaceuticals AGIO:US $ 89.22M 2M
Akebia Therapeutics AKBA:US $ 117.24M 24.86M
Amgen AMGN:US $ 3.77B 854M
AstraZeneca AZN:LN 7.09B 1.67B
Bayer BAYN:GR 9.25B 765M
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Bluebird Bio BLUE:US $ 244M 29.31M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Cytokinetics CYTK:US $ 47.16M 4.03M
Dicerna Pharmaceuticals DRNA:US $ 76.71M 4.1M
Eisai 4523:JP Y 153535M 4141M
Eli Lilly And LLY:US $ 5650.3M 202.4M
Esperion Therapeutics ESPR:US $ 90.8M 14.4M
Exelixis EXEL:US $ 274.84M 29.08M
Genmab GEN:DC 1.05B 108M
Glaxosmithkline GSK:US 6.42B 692M
Immunogen IMGN:US $ 44.32M 305K
Macrogenics MGNX:US $ 71.04M 2.86M
Merk MRK:US $ 9905M 839M
Mirati Therapeutics MRTX:US $ 132.42M 24.38M
Moderna Inc MRNA:US 671M 174.78M
Nektar Therapeutics NKTR:US $ 133.04M 1.14M
Neurocrine Biosciences NBIX:US $ 205.1M 10.6M
Novartis NOVN:VX 9.82B 464M
Pfizer PFE:US $ 13063M 3998M
Puma Biotechnology PBYI:US $ 78.21M 14.35M
Seattle Genetics SGEN:US $ 478.08M 23.68M
Ultragenyx Pharmaceutical RARE:US $ 169.75M 36.21M
Xencor XNCR:US $ 49.64M 5.92M
YTE INCY:US $ 505.92M 119.36M